Please wait while the transcript is being prepared...
0:00
Welcome to this
Henry Stewart Talk
on cardiovascular prevention
in type 2 diabetes.
My name is Eberdhard Standl, and
I'm working at the Munich Diabetes
Research Group at the
Helmholtz Center in Munich.
0:19
These are my disclosures.
0:24
We all know the clinical
manifestations of atherothrombosis
in people with type 2 diabetes are
abundant, and particularly at heart,
but also at the brain, at
the peripheral arteries
and also the renal arteries
and the abdominal aorta.
0:52
Indeed it has been found
that type 2 diabetes seems
to be an equivalent of
coronary artery disease.
Now this has been based
on this landmark study,
at the so-called East
West Study in Finland.
We are looking here,
and actually the study
has been performed in the 1980s
and early 1990s in Finland,
so actually last century.
And what we see here
on the right side,
diabetic patients with no
prior myocardial infarction
has a risk of around 20% over seven
years from myocardial infarction,
and this is more or less identical
with risk in non diabetics
with a prior myocardial infarction.
So in other words,
somebody with diabetes
is at the same risk
level than somebody
without diabetes with a
prior myocardial infarction.
Of course, on the far right
side, patients with diabetes
and a prior myocardial infarction
are at an enormously high risk.
